Skip to content

Effects of mucoadhesive paste contains olive leaf extract in the treatment of Recurrent Aphthous stomatitis (RAS) compared with topical corticosteroid

Effects of mucoadhesive paste contains olive leaf extract in the treatment of Recurrent Aphthous stomatitis (RAS) compared with topical corticosteroid

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015080723542N1
Enrollment
26
Registered
2015-09-12
Start date
2015-09-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent oral Aphthous. Recurrent aphthous ulcer

Interventions

Intervention 1: Intervention group: mucoadhesive paste contains Olive leaf extract. Instruction of drug usage is 4 times per day, 3 times prior each meal and the last time, 20 min prior the sleeping.
Treatment - Drugs
Intervention group: mucoadhesive paste contains Olive leaf extract. Instruction of drug usage is 4 times per day, 3 times prior each meal and the last time, 20 min prior the sleeping. Evaluation and p
Positive control group:Tropical glucocorticoid (mucoadhesive paste contains triamcinolone) with the same instruction that used in interventional group.
Negative control group: mucoadhesive paste without any drug with the same instruction that used in interventional group.

Sponsors

Vice chancellor of Research and Technology of Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: having 1-5 minor aphthous ulcer and their ulcers diameter were less than 5mm; having pain, without unusual sense of paresthesia and anesthesia; filling informed consent form for participation in this study. Exclusion criteria: having a history of drug hypersensitivity; pregnancy and breast feeding; having the history of systemic disorders or Behcet,s syndrome; receiving any other drug comprising NSAIDs or antihistamines in last 1 month; receiving any other drug for curing the ulcers from 72 hours prior the beginning the study; receiving systemic antibiotics from 2 weeks prior the beginning the study; Aphthous ulcers nearby trauma from sharp-edged teeth, broken restorations, orthodontic appliance or partial denture

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Surface of the ulcer. Timepoint: days 0, 1, 2, 5, and 7. Method of measurement: by stereological method of point counting method of cavalieri on ulcer photographs.;Pain. Timepoint: days 0, 1, 2, 5, and 7. Method of measurement: VAS ruler of pain.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Zahra Heidari

Zahedan University of Medical Sciences

histology@ymail.comhistology_iri@yahoo.com+98 54 3329 4390

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026